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Obesity and consumption of a high-fat diet are known to increase the risk of Alzheimer’s disease (AD).
Diets high in fat also increase disease neuropathology and/or cognitive deﬁcits in AD mouse models.
However, the effect of a high-fat diet on both the neuropathology andmemory impairments in the triple-
transgenicmousemodel of AD (3xTgAD) is unknown. Therefore, groups of 2-month-oldmale 3xTgADand
control (non-Tg) miceweremaintained on a high-fat or control diet andmemory was assessed at the age
of 3e4, 7e8, 11e12, and 15e16 months using a series of behavioral tests. A comparable increase in body
weightwas observed in non-Tg and3xTgADmice after high-fat feeding at all ages tested but a signiﬁcantly
greater increase in epididymal adipose tissuewas observed in 3xTgADmice at the age of 7e8,11e12, and
15e16months. A high-fat diet causedmemory impairments in non-Tg controlmice as early as the age of 3
e4months. In 3xTgADmice, high-fat consumption led to a reduction in the age of onset and an increase in
the extent of memory impairments. Some of these effects of high-fat diet on cognition in non-Tg and
3xTgAD mice were transient, and the age at which cognitive impairment was detected depended on the
behavioral test. The effect of high-fat diet onmemory in the 3xTgADmicewas independent of changes in
AD neuropathology as no signiﬁcant differences in (plaques, oligomers) or tau neuropathology were
observed. An acute increase in microglial activationwas seen in high-fat fed 3xTgADmice at the age of 3
e4 months but in non-Tg control mice microglial activation was not observed until the age of 15
e16months. These data indicate therefore that a high-fat diet has rapid and long-lasting negative effects
onmemory in both control and ADmice that are associatedwith neuroinﬂammation, but independent of
changes in beta amyloid and tau neuropathology in the AD mice.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.1. Introduction
Alzheimer’s disease (AD) is the most common form of dementia
and is a signiﬁcant health problem worldwide. AD is characterized
by the presence of beta amyloid (Ab) plaques and neuroﬁbrillary
tangles within the brain and patients present with cognitive deﬁcits
including impairments in learning and memory. The occurrence of
AD is mostly sporadic affecting individuals over the age of 65 years.
However, there are several factors that can increase AD risk
including diabetes, stroke, atherosclerosis, and obesity and/or
metabolic syndrome.e CC BY license (http://
ty of Life Sciences, The Uni-
9PT, UK. Tel.: þ44 161 275
.uk (C.B. Lawrence).
Published by Elsevier Inc. All righObesity is amajor health problem associatedwith increased risk of
several diseases such as diabetes. However, obesity atmidlife can also
increase the risk of dementia and AD later in life (Beydoun et al.,
2008; Fitzpatrick et al., 2009; Gustafson et al., 2003; Hassing et al.,
2009; Kivipelto et al., 2005; Profenno et al., 2009; Rosengren et al.,
2005; Whitmer et al., 2005, 2007, 2008), an effect that is indepen-
dent of the conditions associated with obesity that are also risk fac-
tors for AD, such as type 2 diabetes and cardiovascular disease
(Hassing et al., 2009; Whitmer et al., 2005, 2007). This relationship
between obesity and AD appears to depend on age as obesity can
decrease the risk of AD in later life (Fitzpatrick et al., 2009) andweight
loss actually precedes disease onset (Buchman et al., 2005; Stewart
et al., 2005). Obesity is often caused by and is associated with, con-
sumption of diets that are high in fat. The prevalence of AD is greater
in countries with higher intake of high fat and/or calorie diets but
lower in those that consume diets low in fat (Grant,1997; Panza et al.,
2004). Furthermore, epidemiologic studies suggest diets high ints reserved.
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development of AD (Eskelinen et al., 2008; Grant, 1999; Kalmijn et al.,
1997; Laitinen et al., 2006; Luchsinger et al., 2002), and this risk is
higher in individuals with the APOE ε4 allele (Laitinen et al., 2006;
Luchsinger et al., 2002).
Disease neuropathology and/or behavioral deﬁcits are enhanced
in mouse models of AD that are maintained on a high-fat diet
(without high levels of cholesterol) (Herculano et al., 2013; Ho et al.,
2004; Julien et al., 2010; Maesako et al., 2012a; Pedrini et al., 2009;
Phivilay et al., 2009). There are several well-characterized mouse
models of AD, most with mutations in amyloid precursor protein
(APP) and/or presenilin 1/2 (PS1/2) that present with Ab plaques
only. The triple-transgenic AD (3xTgAD) mouse has mutations in
APPSwe, PS1M146V, and tauP301L, and as a consequence, develops
temporal- and region-speciﬁc Ab plaques and tangle-like pathology
that closely resemble the pathology seen in the human AD brain, in
addition to developing functional impairments, including learning
and memory deﬁcits (Billings et al., 2005; Oddo et al., 2003a,
2003b). The 3xTgAD mouse does not present with an aggressive
pathology, as we do not observe Ab plaques and tangle-like pa-
thology until approximately at the age of 12 months, which is after
cognitive deﬁcits are detected (Billings et al., 2005; Knight et al.,
2012, 2013). The 3xTgAD mouse therefore allows us to identify
the effect of a high-fat diet before signiﬁcant AD neuropathology,
and to also study the relationship between Ab plaques and tau.
In humans, the severity of AD-related neuropathology especially
Ab plaque burden, does not always correlate with, or is predictive
of, cognitive deﬁcits, and memory impairments can occur in mouse
AD models in advance of overt Ab plaque (and tangle) pathology
(Billings et al., 2005; Oddo et al., 2003b; Serrano-Pozo et al., 2011).
Most studies to date examining the role of high-fat diets in AD
mouse models have assessed neuropathology only (Julien et al.,
2010; Pedrini et al., 2009; Phivilay et al., 2009) and few have
monitored both neuropathology and memory (Herculano et al.,
2013; Ho et al., 2004; Maesako et al., 2012a). Furthermore, most
of these studies identifying an effect of a high-fat diet in AD on
neuropathology and behavior have modiﬁed diet in AD mice only
and have not studied the effect of diet in control animals (Ho et al.,
2004; Maesako et al., 2012a). As high-fat diets have been shown to
affect memory in cognitively-normal rodents (McNeilly et al., 2011;
Pistell et al., 2010; Winocur and Greenwood, 2005), it is not clear
whether the cognitive deﬁcits observed in AD mice fed a high-fat
diet are related to or independent of AD pathology. Finally, most
reports on the changes in cognition and/or neuropathology in high-
fat fed AD mice have studied just one time point, and thus only
report effects at a single stage and/or severity of the disease. It is
possible that some of the effects of a high-fat diet in AD might be
transient, which will be missed in such studies.
The aim of this study therefore was to characterize longitudi-
nally the impact of a high-fat diet on both cognition and neuropa-
thology in male 3xTgAD and non-transgenic (non-Tg) control mice.
Memory was assessed using a battery of behavioral tests. No study
to date has compared the effects of a high-fat diet on both cognition
and neuropathology in 3xTgAD mice and we show that a high-fat
diet impairs memory in both the non-Tg control and 3xTgAD
mice, the effects of which depend on the behavioral test used and
duration of diet. Effects of high-fat diet on cognition in the 3xTgAD
mice occurred without any signiﬁcant effect on AD neuropathology.
2. Methods
2.1. Animals and diet
Male 3xTgAD mice expressing mutant PS1M146V, APPSwe,
TauP301L, and control non-Tg (129/C57BL6) mice were originallysupplied by Frank LaFerla (Irvine, CA, USA) (Oddo et al., 2003b) and
an in-house colony established inManchester. All micewere kept in
standard housing conditions (humidity 50%e60%, temperature
21 1 C, 12:12 hour light-dark cycle with lights on at 07:00 hours)
and given ad libitum access to standard rodent chow and water
unless stated. All animal experiments were carried out in accor-
dance with the United Kingdom Animals (Scientiﬁc Procedures) Act
1986. At the age of 8 weeks 3xTgAD and non-Tg control mice were
placed on either a high-fat diet (60% energy from fat, 35% fat con-
tent by weight, 13% saturated fatty acids, 58G9, Test Diets, supplied
by IPS Product Supplies Ltd, UK) or control diet (12% energy from
fat, 5% fat content by weight, 0.78% saturated fatty acids, 58G7).
Separate groups of mice were maintained on their respective diets
until the age of 3e4 (n ¼ 10e12/group), 7e8 (n ¼ 10e11/group),
11e12 (n ¼ 9e10/group), or 15e16 (n ¼ 6e10/group) months when
behavioral tests were performed. Body weight was monitored in all
mice from weaning until behavioral assessment. There were a few
deaths because of unknown causes over the cause of the study, and
these animals were not included in the analyses (7e8months: non-
Tg control n ¼ 1; 11e12 months: 3xTgAD control n ¼ 1, 3xTgAD
high-fat n ¼ 1; 15e16 months: non-Tg high-fat n ¼ 3, 3xTgAD
control n ¼ 2, 3xTgAD high-fat n ¼ 1).
2.2. Behavioral tests
Male non-Tg control and 3xTgAD mice were subjected to the Y-
maze spontaneous alternation, smell recognition, novel object
recognition, and Morris water maze (MWM) tests. On the days of
behavioral evaluation, home cages were placed in the testing room
30 minutes before testing to allow habituation. All behavioral ob-
servations were made between 1000 hours and 1600 hours. The
order of observation during this period was randomized across
animals and all subsequent analysis was performed blinded to ge-
notype and diet. No more than one behavioral test was completed
during any single day. All equipment was cleaned between animals.
2.2.1. Y-maze spontaneous alternation test
Short-term working memory was assessed in the Y-maze
spontaneous alternation test using a black opaque Perspex Y-maze
with 3 arms (A, B, and C) each containing a visual cue (arm di-
mensions; 15 cm 10 cm  10 cm). Each animal was placed in turn
in armA of the Y-maze and allowed to explore for 8minutes and the
arm entries made by each animal were recorded. Arm entry was
deﬁned as having all 4 paws in the arm. Spontaneous alternation
was deﬁned as a successive entry into 3 different arms, on over-
lapping triplet sets (Hiramatsu et al., 1997;Wall andMessier, 2002).
The percentage number of alternations was calculated as the
number of actual alternations divided by the maximum number of
alternations (the total number of arm entries minus 2). The total
number of moves was also recorded as an index of ambulatory
activity (Hiramatsu et al., 1997).
2.2.2. Smell recognition test
Short-term non-associative memory based on the natural
exploration of novelty inmicewas assessed in the smell recognition
test. All mice were habituated to a black opaque polycarbonate
circular arena (diameter, 30 cm  height, 21 cm) for 5 minutes over
2 days. On the day of testing, mice were placed in the arena and
allowed to explore 2 identical unfamiliar scented balls for 10 mi-
nutes (phase 1). The scented balls were placed in the center of the
arena, 5 cm from the edge and 8 cm away from each other. The
hollow balls (Chad Valley, UK) were ﬁlled with cotton wool and
0.5 mL of scent (orange, lemon, vanilla, or almond, Dr Oetker Ltd,
UK) was evenly distributed into the balls via small holes. Mice were
then removed, one of the balls was replaced with a novel scented
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arena and allowed to explore for a further 4 minutes (phase 2). The
novel scented ball was placed randomly in either the left or right
position. All behavior was recorded with a camera (Sanyo Xacti
VPC-C4, SANYO Fisher, CA, USA) and MP4 video-clips were con-
verted to an AVI format using Pazera MP4 to AVI converter 1.3
(Pazera-Software, PL). The duration (seconds) spent exploring the
scented balls was then measured using Observer 5.0 software
(Noldus, Wageningen, the Netherlands). Explorationwas deﬁned as
the amount of time the animals spent with their nose pointing
within 2 cm of the scented balls. The percentage time spent
exploring the scented balls was calculated for phases 1 and 2.
2.2.3. Novel object recognition test
Short-term non-associative memory based on the natural
exploration of novelty in mice was also assessed in the novel object
recognition test. The task was performed the same as the smell
recognition task, but during phase 1 of the task the mice were
placed in the arena and allowed to explore 2 identical unfamiliar
wooden painted trial objects (Universe of Imagination, Geoffrey,
Inc, UK) for 10 minutes. Mice were then removed and one of the
objects was replaced with a novel object that varied in shape and
color. After an interval of 1 hour, mice were allowed to explore the
familiar object and the novel object for 4 minutes. The time spent
exploring the familiar and novel objects was calculated for phases 1
and 2 as for the smell recognition test.
2.2.4. MWM
Spatial reference memory was assessed using the MWM using
a 1.2 m diameter (height, 25 cm) circular white opaque plastic
tank that contained water maintained at a temperature of
21 Ce22 C andmade opaque using water-soluble nontoxic white
paint (Universe of Imagination, Geoffrey Inc, UK). During the
MWM test, mice were given 2 days of visual platform training
followed by 8 days of hidden platform training and a 1 day probe
trial (based on protocol by Vorhees and Williams (2006)). Brieﬂy,
for the acquisition of the visual platform training, mice were
placed into the maze without spatial cues, and allowed to locate a
visual ﬂagged platform. If the platform was not found within
2 minutes, the mouse was gently guided to it. Mice were given 4
trials each day for 2 days with a different start position and ﬂag-
ged platform location each trial. For the acquisition of the hidden
platform test, 4 trials per day were conducted for 8 days. The
sequence of start positions was different on each training day and
visual spatial cues were located outside the tank. The latency to
ﬁnd the platform was recorded with a maximum of 2 minutes
allowed. To test memory retention of the platform location, mice
underwent a probe trial 24 hours after the ﬁnal hidden platform
training trial. During the probe trial, the platform was removed,
and the mouse was placed in the pool and allowed to swim for
30 seconds. Time spent in each quadrant was recorded. Each trial
was monitored and analyzed using a CCTV tracking camera (Vista
protos IV, UK) and 2020 PLUS tracking software (HVS Image,
Buckingham, UK). The escape latency (second) during both visual
platform and hidden platform training and the percentage time in
the target quadrant during the probe trial and swim speed (meter/
second) were calculated.
2.3. Tissue preparation
After the behavioral tests all animals were terminally anes-
thetized with 3.5% isoﬂurane (30% O2 and 70% N2O) and 0.9% saline
was perfused-transcardially. The brain was rapidly removed and
one hemisphere immerse-ﬁxed in 4% paraformaldehyde at room
temperature for 24 hours. This hemisphere was then cryoprotectedin 30% sucrose (in 0.1 M phosphate buffer [PB]) at 4 C for 24 hours
before being frozen in isopentane on dry ice. The hippocampus was
dissected from the other hemisphere of the brain and frozen on dry
ice. All samples were stored at 80 C until assay. One epididymal
fat pad was also dissected and weighed.
2.3.1. Immunohistochemistry
Coronal 30 mm brain sections were cut (from 1.34 mm
to 3.88 mm relative to bregma according to the atlas of Paxinos
and Franklin (2001)), on a freezing sliding microtome (Bright
8000-001, Bright Instrument Co Ltd, UK). Immunohistochemistry
for either Ab or phosphorylated tau was then performed on free-
ﬂoating brain sections. Brieﬂy, endogenous peroxidase was
removed before treatment in blocking solution (10% normal horse
serum in PB/0.3% triton). Sections were then incubated at 4 C
overnight with either a mouse monoclonal anti-human amyloid
6E10 (1:3000, Covance-Signet Laboratories, UK) for Ab or mouse
monoclonal anti-human PHF-tau (AT8; 1:1000, Autogen Bioclear,
UK) for hyperphosphorylated tau. After washes in PB/0.3% triton,
sections were treated for 2 hours in a biotinylated horse anti-mouse
IgG antibody (1:500; Vector Laboratories Ltd, Peterborough, UK).
Following washes (in 0.1 M PB), sections were immersed in avidin-
biotin-peroxidase complex (ABC, Vector Laboratories Ltd) for
30 minutes, rinsed in 0.1 M PB and color-developed using a 0.05%
diaminobenzidine solution (in 0.01% H2O2). Sections were mounted
onto gelatin-coated slides, dried, and coverslipped before viewing
under a light microscope. The number of immunopositive cells
(neurons) expressing tau was counted unilaterally, using a light
microscope, throughout the hippocampus. The average number of
cells per section was calculated and the group mean determined.
The Ab plaque burden was determined throughout in the hippo-
campus. The plaque area was measured in each section and the
plaque burden calculated as average plaque area/section (mm2).
To detect microglia, immunohistochemistry was performed as
previouslymentioned but using a rabbit anti-Iba1 primary antibody
(1:2000, Wako Chemicals, Germany) and a biotinylated goat anti-
rabbit IgG antibody (1:500; Vector Laboratories Ltd), all in 2%
normal goat serum in PB/0.3% triton. Activated microglia
throughout the hippocampus were identiﬁed according to previous
studies. Drake et al., 2011 deﬁned by either an increase in Iba1
staining; enlarged cell bodies; complete or partial loss of thin
elongated process. The number of activated microglia per section
was counted and the average calculated. For all immunohisto-
chemical analyses the investigator was blinded to genotype and
diet.
2.3.2. Ab oligomer enzyme-linked immunosorbent assay
The hippocampus of control and high-fat fed 3xTgADmice, at all
ages tested, were prepared by homogenization in extraction buffer
(50 mM Tris-Cl, 150 mM NaCl, 1% CHAPS, pH 7.6, containing pro-
teases inhibitors) and samples were left to stand for 3 hours. The
homogenates were then centrifuged at 15,000 rpm at 4 C for
30 minutes. Human Ab oligomers were analyzed in the hippo-
campal supernatant by enzyme-linked immunosorbent assay
(ELISA) (IBL International, Germany) according to manufacturer’s
instructions. The ELISA uses mouse monoclonal anti-human Ab (N)
(82E1) antibodies that recognize the N-terminus of human Ab
speciﬁcally, with 2 or more epitopes. The level of oligomers in the
hippocampus of non-Tg control mice was not tested, as no human
oligomers are detected in the brain of these mice (data not shown).
2.4. Statistical analysis
Data are represented as mean  standard error of the mean.
Epididymal fat weight, evaluation of memory in the spontaneous
Fig. 1. Body weight of 3xTgAD and non-Tg mice in response to a high-fat diet. Male 3xTgAD and non-Tg control mice were maintained on either a control or high-fat diet from the
age of 8 weeks (at the age of 2 months) and body weight was assessed in separate groups of mice at the age of 3e4 (A), 7e8 (B), 11e12 (C), and 15e16 (D) months. Data are means 
SEM, n ¼ 6e12/group. * p < 0.05, ** p < 0.01, *** p < 0.001 non-Tg versus 3xTgAD mice on control diet; ## p < 0.01, ### p < 0.001 non-Tg versus 3xTgAD mice on high-fat diet; $ p <
0.05, $$ p < 0.01, $$$ p < 0.001 non-Tg on a control versus high-fat diet; & p < 0.05, && p < 0.01, &&& p <0.001 3xTgAD on a control versus high-fat diet. Three-way repeated measures
ANOVAs with Scheffe post hoc analysis. Abbreviations: ANOVA, analysis of variance; SEM, standard error of the mean.
Table 1
Epididymal fat weight of 3xTgAD and non-Tg mice in response to a high-fat diet
Non-Tg 3xTgAD
Control High-fat Control High-fat
3e4 mo 0.50  0.04 1.46  0.12a 0.37  0.02 1.00  0.09a,c
7e8 mo 0.55  0.08 1.62  0.09a 0.50  0.04 2.51  0.36a,b
11e12 mo 0.73  0.11 1.50  0.09 0.54  0.05 4.75  0.59a,c
15e16 mo 1.21  0.14 1.35  0.27 0.67  0.09 5.56  0.85a,c
Mice weremaintained on a high-fat or control diet and separate groups of micewere
monitored until the age of 3e4, 7e8, 11e12, or 15e16 months when epididymal fat
pad weight (g) was assessed. Data are mean  SEM, n ¼ 6e12/group. a p < 0.001
versus control fed mice of same genotype and b p < 0.01, c p < 0.001 versus non-Tg
mice on the same diet. Two-way ANOVA with Bonferroni post hoc analysis.
Key: ANOVA, analysis of variance; SEM, standard error of the mean.
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examined using a 2-way analysis of variance (ANOVA) with
Bonferroni post hoc analysis and for the smell recognition, novel
object tests, and neuropathology a Student t tests was used. Morris
water maze training was assessed between cohorts on individual
training days and compared within cohorts between the ﬁrst day of
training and successive days of training to assess improvement over
time via 3-way repeated measures ANOVAs with Scheffe post hoc
analysis, as was body weight. The probe test was analyzed using a
2-way ANOVA with Bonferroni post hoc analysis. Statistical signif-
icance was taken at p < 0.05.
3. Results
3.1. High-fat diet increased body weight and fat mass in both non-
Tg and 3xTgAD mice
For all groups of mice at the age of 1 month, there was no sig-
niﬁcant difference in body weight between non-Tg and 3xTgAD
mice (Fig. 1). By the age 2 months, before modifying diet, 3xTgAD
mice weighed signiﬁcantly (p < 0.05e0.001) more than non-Tg
control mice in all groups.
At the age of 3e4 months, non-Tg mice on a high-fat diet were
signiﬁcantly (p< 0.001; Fig. 1A) heavier than those maintained on a
control diet, but no difference was observed between 3xTgAD mice
on a control versus high-fat diet. As at the age of 2 months, 3 to 4-
month-old 3xTgAD mice weighed signiﬁcantly (p < 0.001) more
than non-Tg mice when on a control diet. At the age of 7e8, 11e12,
and 15e16months, both 3xTgAD and non-Tgmice on a high-fat diet
weighedmore than their respective control fed mice, and there was
now no difference in body weight between control-fed non-Tg and
3xTgAD mice (Fig. 1BeD).
At all ages tested male 3xTgAD mice on a control diet displayed
no difference in epididymal fat pad weight compared with thecontrol fed non-Tg mice (Table 1). High-fat feeding led to a signif-
icant (p < 0.001) increase in epididymal fat pad weight in both
3xTgAD and non-Tg mice at the age of 3e4 and 7e8 months
compared with their respective control fed mice. Epididymal fat
pad weight was signiﬁcantly (p < 0.01e0.001) lower in the 3xTgAD
than the non-Tg mice on a high-fat diet at the age of 3e4 months
but higher in 3xTgAD mice at the age of 7e8 months. At the age of
11e12 and 15e16 months, epididymal fat pad weight was not
different in non-Tg mice on a high-fat diet, whereas it was signiﬁ-
cantly (p < 0.001) higher in the 3xTgAD mice on a high-fat diet
compared with their respective control fed mice.
3.2. High-fat diet impaired memory in non-Tg and 3xTgAD mice
3.2.1. Y-maze
At the age of 3e4 months, there was no signiﬁcant effect of
genotype or diet on memory performance in the Y-maze (Fig. 2A).
By the age of 7e8 months, 3xTgAD mice showed a diet-
independent decrease (18% and 24%; p < 0.05) in percentage
Fig. 2. High-fat diet impairs learning in the Y-maze spontaneous alternation test in 3xTgAD and non-Tg mice. Male 3xTgAD and non-Tg control mice were maintained on either a
control or high-fat diet from the age of 8 weeks. Cognitive function was assessed in the Y-maze spontaneous alternation test in separate groups of mice at the age of 3e4 (A), 7e8 (B),
11e12 (C), and 15e16 (D) months. Data are means  SEM. n ¼ 6e12/group. * p < 0.05, ** p < 0.01, *** p < 0.001 versus non-Tg mice on the same diet, ## p < 0.01, ### p < 0.001 versus
control-fed mice of the same genotype. Two-way ANOVA with Bonferroni post hoc analysis. Abbreviations: ANOVA, analysis of variance; SEM, standard error of the mean.
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fewer percentage alternations (19%; p < 0.01) were still detected in
11 to 12-month-old control fed 3xTgAD compared with non-Tg
mice (Fig. 2C). At the age of 11e12 months, high-fat diet impaired
memory (26% reduction; p < 0.001) in non-Tg mice. However, a
high-fat diet did not affect memory in 11 to 12-month-old 3xTgAD
mice. At the age of 15e16 months, 3xTgAD mice on a control diet
performed fewer percentage alternations (19% p < 0.001; Fig. 2D)
than non-Tg mice. A high-fat diet not only impaired memory in 15
to 16-month-old non-Tg mice but also affected cognition in 3xTgAD
mice as less percentage alternations were observed in high-fat
compared with control fed mice for both genotypes (24% and
19%; p < 0.001 and p < 0.01 for non-Tg and 3xTgAD, respectively).
The number of moves was transiently decreased in 3xTgAD mice at
the age of 3e4 and 7e8months but at all ages tested, a high-fat diet
had no effect on the total number of moves in both non-Tg and
3xTgAD mice (data not shown).
3.2.2. Smell recognition
At the age of 3e4, 7e8, 11e12, and 15e16 months, there was no
difference in exploration of identical scented balls during phase 1 of
the smell recognition test for all groups of mice (data not shown).
During phase 2, after a delay of 3minutes, non-Tgmice at all ages on
a control diet spent a signiﬁcantly (p < 0.05) higher percentage of
time exploring the novel scented ball than the familiar scented ball
indicating memory formation (Fig. 3AeD). Memory was unim-
paired in 3xTgAD mice on a control diet at earlier time points as
mice spent more time exploring the novel scented ball at the age of
3e4 months (p < 0.01) and more time exploring the familiar
scented ball at the age 7e8 months (p < 0.05). However, memorywas impaired in control fed 3xTgAD mice at the age of 11e12 and
15e16 months as no difference in exploration between the novel
and familiar smell was observed. High-fat feeding transiently
impairedmemory in non-Tgmice as no preference for exploring the
novel or familiar scented ball was detected at the age of 3e4 and
7e8months but by the age of 11e12 and 15e16months high-fat fed
non-Tg mice spent more time exploring the novel scented ball (p <
0.05). In contrast, the 3xTgAD mice on a high-fat diet showed
impaired memory at all ages, as they did not show a preference for
the novel or familiar smell.
3.2.3. Novel object recognition
At the age of 3e4, 7e8, 11e12, and 15e16 months, there was no
difference in exploration of identical objects during phase 1 of the
test in both non-Tg and 3xTgADmice (data not shown). At the age of
3e4 and 7e8 months, during phase 2 after an interval of 1 hour,
non-Tg mice on a control or high-fat diet spent signiﬁcantly (p <
0.05 and p < 0.001) more time exploring the novel versus the
familiar object (Fig. 4A and B). At the age of 11e12 and
15e16 months, the non-Tg mice on a control diet also spent
signiﬁcantly more time exploring the novel versus the familiar
object (p < 0.01, Fig. 4C and D), whereas the high-fat diet impaired
memory at these ages. In 3xTgADmice, memory was impaired at all
ages on both control and high-fat diet (Fig. 4AeD).
3.2.4. Morris water maze
By the second day of visual platform training in the MWM
there was no signiﬁcant difference in escape latency between any
group at the age of 3e4, 7e8, 11e12, or 15e16 months (data not
shown).
Fig. 3. High-fat diet impairs learning in the smell recognition test in 3xTgAD and non-Tg mice. Male 3xTgAD and non-Tg control mice were maintained on either a control or high-fat
diet from the age of 8 weeks. Cognitive function was assessed in the smell recognition test in separate groups of mice at the age of 3e4 (A), 7e8 (B), 11e12 (C), and 15e16 (D) months.
During phase 1, the mice were placed in an arena for 10 minutes with 2 identically scented balls (data not shown). During phase 2, after an interval of 3 minutes, the mice were
placed back into the arena with one familiar scented ball (presented in phase 1) and one novel scented ball for 4 minutes and percentage time exploring balls was compared. Data
are means  SEM. n ¼ 6e12/group. * p < 0.05, ** p < 0.01 for novel versus familiar smell; Student t test. Abbreviation: SEM, standard error of the mean.
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control diet showed signiﬁcantly decreasing escape latency over
training days at all ages tested (days 2e8 versus day 1; p <
0.05e0.001), whereas the 3xTgADmice on a control diet showed no
evidence of learning. On a high-fat diet, non-Tg mice got quicker
over training days at the age of 3e4, 7e8, 11e12, and 15e16months
(days 2e8 versus day 1; p< 0.05e0.001), whereas the 3xTgADmice
on a high-fat diet, got quicker only at the age of 3e4 months (days
7e8 versus day 1; p < 0.05) yet were unable to learn at the age of
7e8, 11e12, and 15e16 months. On individual training days there
was no signiﬁcant difference in escape latency between the cohorts.
At all ages tested during the probe test, 3xTgAD mice on either a
control or high-fat diet spent signiﬁcantly less time in the target
quadrant when compared with their respective fed non-Tg mice
(p < 0.05e0.001, Fig. 5EeH). High-fat feeding had no effect on
memory in 3 to 4-month-old 3xTgAD or non-Tg mice. However, by
the age of 7e8 months, a high-fat diet impaired memory as a
decrease (30%e32%) in the time spent in the target quadrant was
observed in both high-fat fed 3xTgAD and non-Tg mice when
compared with control fed mice. Effects of high-fat diet on memory
were transient as at the age of 11e12 and 15e16 months no dif-
ference in time spent in the target quadrant was observed between
3xTgAD or non-Tg mice on either a control or high-fat diet. During
the probe test at the age of 3e4 months swim speed was signiﬁ-
cantly higher in 3xTgAD mice compared with non-Tg control mice
on either diet (non-Tg, control 0.23  0.01 m/s, high-fat 0.24 0.01m/s; 3xTgAD, control 0.29 0.01m/s, high-fat 0.29 0.01m/s;
p < 0.001, 3xTgAD versus non-Tg on either diet). At all other ages
(7e8, 11e12, and 15e16 months) there was no longer an effect of
genotype on swim speed. There was no effect diet on swim speed in
all groups of mice at all ages (data not shown).
3.3. High-fat diet had no effect on Ab and tau pathology in 3xTgAD
mice
To assess the effect of a high-fat diet on Ab peptide deposition,
sections from all mice were stained with 6E10, an antibody that
recognizes amino acid residue 1e16 of beta-amyloid. No extracel-
lular Ab plaques were detected in the brains of control or high-fat
fed 3xTgAD mice at the age of 3e4 and 7e8 months but by the
age of 11e12 months, occasional Ab plaques were detected in the
hippocampus of 3xTgAD mice that were more prevalent at the age
of 15e16 months (Table 2 and Fig. 6A). A high-fat diet had no effect
on the Ab plaque burden in the hippocampus of 3xTgADmice at the
age of 11e12 or 15e16months (Table 2 and Fig. 6A). No extracellular
Ab plaques were detected in the brains of non-Tg mice or in the
cortex and amygdala of 3xTgAD mice on either a control or high-fat
diet.
No cells positive for hyperphosphoryated tau were found in the
brain of 3 to 4-month-old 3xTgAD mice. At the age of 7e8, 11e12,
and 15e16 months, tau-positive cells were detected in the hippo-
campus and amygdala. In all brain regions, there was no
Fig. 4. High-fat diet impairs learning in the novel object recognition test in non-Tg mice. Male 3xTgAD and non-Tg control mice were maintained on either a control or high-fat diet
from the age of 8 weeks. Cognitive function was assessed in the novel object recognition test in separate groups of mice at the age of 3e4 (A), 7e8 (B), 11e12 (C), and 15e16 (D)
months. During phase 1, the mice were placed in an arena for 10 minutes with 2 identical novel objects (data not shown). During phase 2, after an interval of 1 hour, the mice were
placed back into the arena with one familiar object (presented in phase 1) and one novel object for 4 minutes and percentage time exploring objects was compared. Data are means
 SEM. n ¼ 6e12/group. * p < 0.05, ** p < 0.01, *** p < 0.01 for novel versus familiar object; Student t test. Abbreviation: SEM, standard error of the mean.
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3xTgAD mice fed a control or high-fat diet (Table 2 and Fig. 6B). No
hyperphosphoryated tau was detected in the brains of non-Tg mice
or in the cortex of 3xTgAD mice on either a control or high-fat diet.
The level of Ab oligomers was analyzed in the hippocampus of
3xTgAD mice by ELISA. There was no difference in the amount of
oligomers detected between control and high-fat fed 3xTgAD mice
at all ages tested (Table 2).
3.4. High-fat diet increases microglia activation in non-Tg and
3xTgAD mice
At the age of 15e16 months, a signiﬁcant (p < 0.05e0.001) in-
crease in the number of activated microglia were detected in the
hippocampus of 3xTgAD mice on either a control or high-fat diet
when compared with non-Tg mice. A high-fat diet increased the
number of activated microglia at the age of 3e4 months in 3xTgAD
mice and at the age of 15e16 months in non-Tg mice (Fig. 7). The
activated microglia were found in the same region of the hippo-
campus (dorsal subiculum) as to where the Ab plaques were
detected in the 3xTgAD mice (Fig. 6A).
4. Discussion
The present study is the ﬁrst to assess longitudinally the effect of
a high-fat diet in both control non-Tg and 3xTgAD mice, and to
simultaneously measure cognitive function and pathology. Wedemonstrate that a high-fat diet increases the onset and severity of
memory deﬁcits in 3xTgAD mice. The effects of a high-fat diet on
cognition in 3xTgAD mice are independent of an effect on AD
neuropathology as no difference was observed in the deposition of
Ab and tau. Furthermore, high-fat feeding also caused memory
impairments in control non-Tg mice.
Overconsumption of diets high in saturated fats is a common
problem in developed countries and is likely the primary cause
of obesity. Obesity is associated with an increased risk of several
peripheral diseases but recent evidence suggests that obesity can
also affect the brain. Midlife obesity and consumption of diets
high in fat are linked to a greater risk of AD in humans (Beydoun
et al., 2008; Eskelinen et al., 2008; Fitzpatrick et al., 2009; Grant,
1999; Gustafson et al., 2003; Hassing et al., 2009; Kalmijn et al.,
1997; Kivipelto et al., 2005; Laitinen et al., 2006; Luchsinger
et al., 2002; Profenno et al., 2009; Rosengren et al., 2005;
Whitmer et al., 2005, 2007, 2008). Several studies have shown
that obesity can also affect the brain in nondemented subjects
and is linked with structural abnormalities, such as reduced
brain and hippocampal volume, atrophy (e.g., temporal lobe), and
white matter lesions (Gazdzinski et al., 2008; Gustafson et al.,
2004a, 2004b; Jagust et al., 2005; Ward et al., 2005). Further-
more, central obesity has been linked with poorer cognition in
elderly nondemented individuals (Jeong et al., 2005). These
studies in obese humans suggest that increased adiposity can
inﬂuence key areas in the brain that regulate memory and are
affected in AD.
Fig. 5. High-fat diet impairs learning in the Morris water maze in 3xTgAD and non-Tg mice. Male 3xTgAD and non-Tg control mice were maintained on either a control or high-fat
diet from the age of 8 weeks. Cognitive function was assessed in the Morris water maze in separate groups of mice at the age of 3e4 (A), 7e8 (B), 11e12 (C), and 15e16 (D) months.
Mice were given 4 trials a day for 8 days of submerged platform training in the MWM (AeD). Twenty-four hours after the ﬁnal trial the mice were given a probe test with no
platform (EeH). Data are mean þ/ SEM. For escape latency, * p < 0.05, ** p < 0.01, *** p < 0.001 day 1 versus days 2e8. For percentage time in target, * p < 0.05, ** p < 0.01, *** p
<0.001 versus non-Tg mice on the same diet, # p < 0.05, ## p < 0.01 versus control-fed mice of the same genotype. Abbreviations: MWM, Morris water maze; SEM, standard error of
the mean.
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in rodents have assessed spatial memory only and have usually
evaluated memory in one behavioral test. The present study used a
battery of tests to assess the effect of high-fat consumption on
spatial and nonspatial memory in mice. Regardless of the test used
a high-fat diet impaired both spatial and nonspatial memory in
non-Tg and 3xTgAD mice. In some behavioral tests a high-fat diet
had a rapid effect on memory, although in other tests an effect was
apparent at a later time point. A difference in the timing of the
detrimental effect of a high-fat diet on cognition has been reported
previously and is dependent on the use of spatial versus nonspatialmemory tests (Kanoski and Davidson, 2011). These data therefore
suggest that different modes of memory are differentially sensitive
to the effects of a high-fat diet. Although the present study dem-
onstrates that a high-fat diet caused a rapid but also long-lasting
impairment in cognition some of these effects, especially in the
non-Tg mice, were transient although this was not observed in all
behavioral tests. The transient nature of the high-fat diet induced
memory impairment is currently not understood. However, overall
these data demonstrate that the choice of timing and the type of
behavioral test used is therefore important when assessing the
cognitive effects of high-fat consumption in mice.
Table 2
A high-fat diet had no effect on Alzheimer’s disease neuropathology in 3xTgADmice
Cortex Hippocampus Amygdala
Control High-fat Control High-fat Control High-fat
Ab
Plaque burden
3e4 mo nd nd nd nd nd nd
7e8 mo nd nd nd nd nd nd
11e12 mo nd nd 680  183 585  264 nd nd
15e16 mo nd nd 2713  458 6177  1845 nd nd
Oligomers (nmol/L)
3e4 mo d d 2.7  0.4 3.9  0.4 d d
7e8 mo d d 4.2  0.4 3.1  0.2 d d
11e12 mo d d 3.6  0.4 3.1  0.3 d d
15e16 mo d d 3.8  0.5 4.1  0.4 d d
Tau
3e4 mo nd nd nd nd nd nd
7e8 mo nd nd 1  1 nd 2  2 1  1
11e12 mo nd nd 7  1 8  3 2  1 1  1
15e16 mo nd nd 8  6 3  1 9  4 12  5
3xTgADmice were maintained on a control or high-fat diet for those aged 3e4, 7e8,
11e12, and 15e16 months. Immunohistochemistry for Ab or hyperphosphorylated
tau was performed using 6E10 and AT8 antibodies, respectively. The average
number of cells per section positive for tau were counted in the cortex, hippo-
campus, and amygdala. The extracellular Ab plaque burden in the hippocampus was
assessed and data are expressed as average plaque area/section (mm2). The
expression of Ab oligomers was analyzed by ELISA in the hippocampus. Data are
mean  SEM, n ¼ 6e12/group.
Key: Ab, amyloid beta; ELISA, enzyme-linked immunosorbent assay; nd, none
detected; d, not analyzed; SEM, standard error of the mean.
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memory in 3xTgAD mice was not associated with a change in the
extentofAband taudeposition. In support, not all studies reporting a
worsening of memory in AD mice fed a high-fat diet have observed
an effect on pathology (Herculano et al., 2013; Phivilay et al., 2009).
However, several studies have shown that high-fat feeding can in-
crease solubleAb and/orAbplaques in thebrainof ADmice (Hoet al.,
2004; Julien et al., 2010; Maesako et al., 2012a; Pedrini et al., 2009).
Ab oligomers are currently thought to be the key species involved in
Ab toxicity (Lesne et al., 2006; Shankar et al., 2008; Walsh et al.,
2002) but in the present study no change in expression of soluble
oligomers was detected in the hippocampus of 3xTgAD mice on a
high-fat diet at any time point. High-fat consumption also caused
memory deﬁcits in control non-Tg mice, which do not present with
Ab or tau neuropathology. Furthermore, intermittent fasting has
been shown to reduce cognitive deﬁcits in 3xTgAD mice without
effecting Ab and tau levels (Halagappa et al., 2007). Thus, the effects
of a high-fat diet on cognition in the present study are therefore
likely not because of changes in AD-related neuropathology.Fig. 6. High-fat diet has no effect on Ab or tau neuropathology in the hippocampus of 3xTgA
high-fat diet from the age of 8 weeks until the age of 11e12 and 15e16 months. Immunohis
AT8 antibodies, respectively. Representative sections for 3xTgAD mice are shown for the h
Quantiﬁcation is presented in Table 2. Scale bars 200 mm. Abbreviation: Ab, beta amyloid.High-fat feeding caused an increase in body weight to the same
extent in non-Tg and 3xTgAD mice. However, after the age of
7e8 months 3xTgAD mice on a high-fat diet had higher epididymal
adipose mass compared with non-Tg control mice suggesting that
the metabolic response to excess calories is different in the 3xTgAD
mice. The present data also conﬁrms a previous study showing that
early in life 3xTgAD mice on a control diet weigh more and have
higher food consumption than non-Tg controls (Knight et al., 2012),
although food intake was not assessed here. This increased body
weight shown here was not because of greater adipose tissue
deposition, at least in the epididymal depots although other
visceral depots and subcutaneous adipose remains to be assessed. It
is likely therefore that other factors contribute to the greater body
weight as 3xTgADmice have longer body lengths and higher spleen
mass (unpublished data). Altered metabolism has also been
demonstrated in the 3xTgAD mouse as after the age of 12 months,
these mice are no longer heavier than the control non-Tg mice even
though food intake is still increased, an observation that might be
because of a higher metabolic rate (Adebakin et al., 2012; Knight
et al., 2012). However, it is likely that body weight and/or obesity
per se may not be the main cause for cognitive deﬁcits as memory
deﬁcits in high-fat fed AD mice can be reduced (with an antioxi-
dant) without an effect on body weight (Herculano et al., 2013).
Furthermore, when body weight is normalized after the high-fat
diet is replaced with control diet, AD mice still experience cogni-
tive deﬁcits (Maesako et al., 2012b). Exercise is also more effective
than diet control at reducing cognitive impairment in high-fat fed
AD mice, even though exercise only induced a minor reduction in
body weight (Maesako et al., 2012b). These data therefore suggest
that long lasting metabolic consequences of high-fat feeding rather
than body weight and/or adiposity are responsible for a reduction
in cognition in mice.
The mechanisms responsible for the effect of a high-fat diet on
memory remain unknown, although there are several possibil-
ities. Neuroinﬂammation and oxidative stress are pathologic
features of AD that are proposed to play a key role in the disease
pathogenesis (Johnston et al., 2011; Verri et al., 2012; Wyss-Coray
and Rogers, 2012). Microglia are the brain-resident “immune”
cells and are proposed to play a key role in many neurodegener-
ative conditions and particularly in AD (Wyss-Coray and Rogers,
2012). Microglial activation was increased in response to a high-
fat diet seen here in both 3xTgAD and non-Tg control mice, and
also in other mouse models of AD (Herculano et al., 2013).
Vascular inﬂammation might also be important in the effects of
obesity on cognition as diets high in fat also increase expression
of vascular inﬂammatory markers in AD mice (Herculano et al.,
2013). Furthermore, when AD transgenic mice (APP23) areD mice. Male 3xTgAD and non-Tg control mice were maintained on either a control or
tochemistry for Ab (A) or hyperphosphorylated tau (B) was performed using 6E10 and
ippocampus indicating the extracellular Ab plaque burden and tau-positive neurons.
Fig. 7. High-fat diet increases microglia activation in the hippocampus of 3xTgAD and non-Tg mice. Male 3xTgAD and non-Tg control mice were maintained on either a control or
high-fat diet from the age of 8 weeks until the age of 3e4 (A), 7e8 (B), 11e12 (C), and 15e16 (D) months. Microglia activation were identiﬁed by increased Iba1 immunopositivity,
enlarged and/or irregular cell bodies, thickened, partial or complete loss of processes and were seen after high-fat feeding in 3xTgAD mice at the age of 3e4 months and non-Tg mice
at the age of 15e16 months. An increase in microglia activation was also observed in control fed 3xTgAD mice over time. (E) Representative photomicrographs in the hippocampus
from 3e4 and 15 to 16-month-old mice. Scale bars 200 mm and 25 mm (insets). * p < 0.05, ** p < 0.01, *** p < 0.001 versus non-Tg group on the same diet; # p < 0.05 versus control
fed of the same genotype.
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offspring (APPþ-ob/ob) showworse cognitive deﬁcits and vascular
inﬂammation that appear before signiﬁcant Ab deposition
(Takeda et al., 2010). Oxidative stress is also a key feature of AD
and can be increased in response to dysregulated inﬂammation.
Heighted oxidative stress is observed after short-term high-fat
feeding in both AD and control mice and antioxidants have beenshown to be reduce the memory deﬁcits in AD mice fed a high-fat
diet (Herculano et al., 2013).
The data in the present study indicate that high-fat diets impair
memory in control and AD mice. It remains to be determined if the
same or different mechanisms impact on memory in control and
3xTgAD mice, though the underlying mechanisms do not involve
exacerbation of Ab and tau pathology.
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